advertisement
11.15 Other drugs in relation to glaucoma (77)
Showing records 1 to 25
Display all abstracts in classification 11.15 Other drugs in relation to glaucoma
Search within classification 11.15 Other drugs in relation to glaucoma79570 Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
Addis VM
Clinical Ophthalmology 2018; 12: 2649-2657
79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Adams CM
Pharmaceutical Research 2018; 36: 25
79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Librando A
International Journal of Ophthalmology 2018; 11: 1936-1940
79977 Effect of a Topical Combination of Latanoprost and Pranoprofen on Intraocular Pressure and the Ocular Surface in Open-Angle Glaucoma Patients
Zhu S
Journal of Ophthalmology 2018; 2018: 7474086
80090 Rho kinase inhibitors for treatment of glaucoma
Mandell KJ
Expert Review of Ophthalmology 2011; 6: 611-622
79432 Oral doxycycline and azithromycin in the management of recurrent conjunctival dehiscence following glaucoma drainage implantation in a child
Kumar P
Journal of AAPOS 2019; 23: 55-57
79954 Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study)
Mostafaei A
International Ophthalmology 2019; 39: 2341-2351
79381 The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology
Hoguet A
Ophthalmology 2019; 126: 611-622
79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Cheng YH
Experimental Eye Research 2019; 179: 179-187
79393 Omidenepag Isopropyl Ophthalmic Solution 0.002%: First Global Approval
Duggan S
Drugs 2018; 78: 1925-1929
80063 Ahmed glaucoma valve implantation versus suprachoroidal silicone tube implantation following the injection of bevacizumab into the anterior chamber in patients with neovascular glaucoma
Simsek T
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 799-804
79438 ACUTE MYOPIA WITH ELEVATION OF INTRAOCULAR TENSION AS AN ADVERSE SIDE EFFECT OF ANTIDEPRESSANT MEDICATION
Hrčková L
Česka a Slovenska Oftalmologie 0; 74: 68-72
80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Zarranz-Ventura J
PLoS ONE 2019; 14: e0209997
80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Fingeret M
Clinical and Experimental Optometry 2019; 102: 541-550
80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Tanihara H
Advances in Therapy 2019; 36: 333-343
79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Kahook MY
American Journal of Ophthalmology 2019; 200: 130-137
79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Stacy R
Pharmaceutical Research 2018; 36: 25
79432 Oral doxycycline and azithromycin in the management of recurrent conjunctival dehiscence following glaucoma drainage implantation in a child
Krishnamurthy R
Journal of AAPOS 2019; 23: 55-57
79954 Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study)
Taheri N
International Ophthalmology 2019; 39: 2341-2351
79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Carlesimo SC
International Journal of Ophthalmology 2018; 11: 1936-1940
79570 Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
Miller-Ellis E
Clinical Ophthalmology 2018; 12: 2649-2657
80063 Ahmed glaucoma valve implantation versus suprachoroidal silicone tube implantation following the injection of bevacizumab into the anterior chamber in patients with neovascular glaucoma
Bilgeç MD
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 799-804
79438 ACUTE MYOPIA WITH ELEVATION OF INTRAOCULAR TENSION AS AN ADVERSE SIDE EFFECT OF ANTIDEPRESSANT MEDICATION
Mojžiš P
Česka a Slovenska Oftalmologie 0; 74: 68-72
80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Gaddie IB
Clinical and Experimental Optometry 2019; 102: 541-550
80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Sala-Puigdollers A
PLoS ONE 2019; 14: e0209997
